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RESUMO 
 
O objetivo deste trabalho foi avaliar separadamente a eficácia do tratamento 
realizado pelo serviço de cirurgia bucomaxilofacial da FOP-UNICAMP em três 
lesões ósseas que podem acometer a região maxilofacial: cisto ósseo simples 
(COS), lesão central de células gigantes (LCCG) e queratocisto odontogênico 
(QO). 1) 12 casos de COS, sendo a curetagem o tratamento de escolha. Nenhuma 
alteração dentária ou sensorial foi percebida e não houve recorrência; 2) 20 casos 
de LCCG, sendo o tratamento de escolha baseado na característica de lesão: 6 
foram tratados por meio de cirurgia (3 ambulatoriais e 3 hospitalares). As demais 
lesões (14) foram tratadas com injeção intra-lesional de triancinolona 
semanalmente, associada a calcitonina (5 casos) ou enucleação (2 casos). Não 
houve recorrência; 3) 53 casos (59 lesões) de queratocisto, sendo que 47 foram 
tratadas por meio de descompressão e 12 por meio de enucleação. Ocorreu 
recidiva em 8 casos (6 por descompressão e 2 por enucleação). Todas estas 
foram tratadas em um segundo momento com enucleação/curetagem, associadas 
a ostectomia periférica. Não houve recorrência após esta segunda abordagem. De 
acordo com a metodologia empregada neste estudo concluímos que os 
tratamentos adotados se mostraram efetivos e com resultados semelhantes aos 
de outros trabalhos na literatura, sendo que a escolha do tratamento a ser 
realizado deve levar sempre em consideração o tipo e tamanho da lesão, bem 
como as condições clínicas/anatômicas e radiográficas da lesão, assim como a 
colaboração do paciente. 
 
Palavras-Chave: tratamento conservador, cisto ósseo simples, lesão central de 
células gigantes, queratocisto odontogênico 
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ABSTRACT 
 
The objective of this study was to evaluate separately the effectiveness of 
the treatment by oral and maxillofacial surgery service by FOP-UNICAMP in three 
bone lesions that may affect the maxillofacial region: simple bone cyst (SBC), 
central giant cell lesion (CGCL) and odontogenic keratocysts (OQ). 1) 12 cases of 
SBC, and curettage treatment of choice. No dental or sensory changes were noted 
and no recurrence, 2) 20 cases of CGCL, and the treatment of choice based on 
characteristic lesions: six were treated by surgery (3 hospital and 3 outpatient). The 
remaining injuries (14) were treated with intra-lesional triamcinolone weekly 
associated with calcitonin (5 cases) or enucleation (two cases). No recurrence, 3) 
53 cases (59 lesions) of OK, and 47 were treated by decompression and 
enucleation through 12. Relapse occurred in 8 cases (6 per second for 
decompression and enucleation). All these were treated in a second time with 
enucleation / curettage associated with periferic ostectomy. There was no 
recurrence after this second approach. According to the methodology used in this 
study, the standard treatment proved effective, with results similar to those of other 
studies in literature, and the choice of treatment to be performed must always take 
into account the type and size of the lesion, as well as clinical 
conditions/anatomical and radiographic lesion, as well as the collaboration of the 
patient.  
 
Key Words: conservative treatment, simple bone cyst, central giant cell lesion, 
odontogenic keratocysts 
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1. INTRODUÇÃO 
 
O estudo das lesões que acometem a cavidade bucal e as regiões anexas 
representa um importante capítulo da Odontologia, em virtude do importante papel 
do cirurgião-dentista em seu diagnóstico e tratamento.  Várias lesões ósseas, de 
origem odontogênica ou não, podem se manifestar primariamente ou 
exclusivamente nos ossos da região maxilofacial. Estas lesões podem se 
apresentar de diferentes formas clínicas e radiográficas. Desta maneira, o 
diagnóstico dessas lesões ósseas, juntamente com a evolução clínica, poderá 
definir qual o melhor tipo de tratamento a ser executado. 
Basicamente, as lesões ósseas dos maxilares são divididas em: 
 
  cistos odontogênicos; 
  cistos não-odontogênicos; 
  tumores odontogênicos 
  tumores não-odontogênicos; 
  lesões inflamatórias dos maxilares; 
  doenças metabólicas e genéticas1  
 
Como descrito anteriormente, cada doença óssea possui um específico 
plano de tratamento, baseado no tipo de lesão e nas evoluções clínica e 
radiográfica da mesma. Desta forma, analisamos 3 lesões ósseas, incluindo as 
características gerais e os tipos de tratamento disponíveis para cada uma destas 
leões. 
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1. Cisto Ósseo Simples 
 
1.1 )  Considerações gerais 
 
Os cistos da região maxilofacial podem ser divididos em cistos verdadeiros 
ou pseudo-cistos, sendo estes últimos, lesões que não apresentam revestimento 
epitelial, entretanto recebem a denominação de “cistos” por alguns autores, devido 
a suas características expansivas e por possuírem uma cavidade1. Os pseudo-
cistos são lesões tais como o cisto ósseo aneurismático, o cisto ósseo estático e o 
cisto ósseo simples (COS)2.   
O COS é uma lesão incomum, apresentando uma prevalência de 1% dos 
cistos não odontogênicos dos maxilares.  Essa lesão é encontrada mais 
freqüentemente durante a segunda década de vida, e sua presença após esse 
período é incomum. Ocorre quase que exclusivamente na mandíbula, com 
predileção pela região de corpo e sínfise mandibular3. 
Por se tratar de uma lesão assintomática e de evolução silenciosa, é quase 
sempre descoberta em exames radiográficos de rotina. Deste modo, a radiografia 
desempenha uma função importante, tanto no diagnóstico, quanto na proservação 
desta lesão, ambas fundamentadas particularmente nesse exame 
complementar4,5.   
Embora muitas teorias tenham surgido para explicar a origem do COS, sua 
etiopatogenia ainda permanece desconhecida, refletindo assim,  numa  variedade  
de  nomes  encontrados  na  literatura  como  “cisto  ósseo hemorrágico”4,  “cisto  
ósseo  traumático”6, “cisto ósseo solitário”7 “cisto de extravasamento”8,“cisto ósseo 
idiopático”9, “cisto ósseo simples”10, entre outros. As três hipóteses mais 
difundidas são: 
 a)crescimento ósseo anormal. Isso porque geralmente o cisto se encontra 
perto de centros cartilaginosos, durante a fase de crescimento; 
 b)degeneração tumoral, como por exemplo, o granuloma central de células 
gigantes; 
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 c)hemorragia intramedular a partir de um trauma local, no qual ocorre falha 
na organização do coágulo e consequentemente liquefação do mesmo (mais 
aceito atualmente)5, 11. 
. 
1.2 )Tratamento 
Diversas formas de tratamento estão citadas na literatura para o COS.  As 
formas variam desde a instituição de um acompanhamento radiográfico da lesão, 
à utilização de uma abordagem cirúrgica para exploração da cavidade, conforme 
mostrado no quadro abaixo (Quadro 1).   
Quadro 1. Tipos de tratamento encontrados para o Cisto ósseo simples 
Tipo de tratamento Autor e ano 
 
Acompanhamento 
 
 
Sapp, 19903  Blum,  195512;  Szerlip,  
196613;   
Exploração cirúrgica + Curetagem 
 
Kaugars  &  Cale,  19874;  Fridrichsen,  
199314; 
Sharma,  196715;  Gowgiel,  197916  
DeTomasi  & 
Hann,   198517;   Whinery,   195518;   
Stimson   & 
McDaniel, 198919 
Exploração cirúrgica 
 
Harris,  197220;  Narang  &  Jarrett,  198021;   
Fredman  &  Beigleman,198522; Winer 
&  Doku,197823;   
Chiba et al., 200224 
 
Exploração cirúrgica + endodontia 
 
Oliveira et al., 200025 ; Newton & Zunt, 
198726 
Sangue autógeno Biewald, 196727 
Osso autógeno 
 
Bennett  &  Chilton  194528;  Robinson  et  
al., 196729 
Osso homógeno Lindsay e Martin, 196630 
Hidroxiapatita  +  Osso  autógeno  +  
sangue autógeno 
Dellinger et al., 199831 
Gelfoam Thoma, 195532 
Tratamento endodôntico 
 
Patrikiou et al., 198133; Ruiz-Hubard & 
Harrison, 198734 
Aspiração com agulha Blum, 195512 
4 
 
Dentre todos os tratamentos encontrados na literatura, os mais empregados 
foram: 
 acompanhamento radiográfico (sem intervenção cirúrgica) 
 exploração  cirúrgica  com  ou  sem  presença  de curetagem  das  
paredes  ósseas;   
 abertura  e  preenchimento  cavitário  utilizando enxerto ósseo.  
 
Blum (1955)12 e Szerlip (1966)13 apresentaram casos de COS, sendo que 
após o diagnóstico clínico e radiográfico optaram pelo acompanhamento da lesão. 
Esses autores avaliaram as lesões através de radiografias por um período de 
cinco anos e observaram que houve resolução completa da lesão sem a 
necessidade de intervenção cirúrgica.   
Bennett e Chilton (1945)28 relataram um caso de COS que foi tratado através 
de  enxerto  ósseo  autógeno.  A grande dimensão da lesão foi fator determinante 
na  escolha  do  tratamento.  Para os autores, a utilização do enxerto em lesões de 
grandes  dimensões  é  mais  indicada,  pois  acelera  o processo de reparo. 
Lindsay e Martin (1966)30 apresentaram um caso de COS, tratado com 
abertura de uma janela na parede externa do cisto e colocação de enxerto ósseo 
homógeno. Nesse caso, o autor afirma que a presença de necrose dos dentes 
associados a lesão auxiliou na osteólise e formação  da  cavidade cística, os 
dentes foram removidos durante o procedimento cirúrgico.  A utilização desse 
tratamento, segundo os autores deve ser realizada em lesões de grandes 
dimensões.  
 Patrikiou et al. (1981)33, avaliaram métodos diferentes de tratamento em 
um paciente que apresentava dois cistos ósseos simples mandibulares. O exame 
radiográfico revelou duas áreas radiolúcidas, uma grande do lado esquerdo da 
mandíbula, bem circunscrita com contorno nítido entre as raízes dos dentes 
envolvidos e outra pequena no lado direito, redonda e bem circunscrita. A lesão do 
lado esquerdo recebeu tratamento convencional com exploração cirúrgica e no 
lado direito foi realizada a endodontia dos dentes que estavam envolvidos na 
lesão.  Os autores observaram que após um período de seis meses  havia  um 
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aumento da reabsorção óssea no lado onde tinha sido realizada a endodontia, ao 
contrário do lado oposto, que se mostrava preenchida com trabeculado ósseo. 
Magliocca et. al. (2007)35 tratou dois pacientes que apresentaram a lesão 
em região de côndilo mandibular. O tratamento foi o mesmo para os dois casos, 
onde, sob anestesia geral e acesso extra-bucal os côndilos foram encontrados. 
Após isso, exploração cirúrgica e curetagem da região foram feitas afim de que 
houvesse estimulação de sangramento. Os pacientes foram acompanhados por 
meio de radiografias. Nenhuma queixa foi relatada pelos pacientes em um 
acompanhamento a longo prazo. 
Ballester et al. (2009)36  realizaram um estudo retrospectivo de 21 COS. O 
diagnóstico foi baseado na anamnese, exame clínico e exames complementares. 
Radiografias panorâmica e periapical foram obtidas em todos os casos, 
juntamente com a tomografia computadorizada, conforme decidido pelo cirurgião. 
Todas as lesões foram submetidas a exploração cirúrgica, e as cavidades 
apresentavam-se vazias em 90,5% dos casos. Em apenas dois pacientes um 
conteúdo vascular foi visto no interior da lesão. Dois pacientes apresentaram 
parestesia pós-operatória do nervo alveolar inferior, havendo melhora da 
parestesia em até 2 semanas pós-operatórias. Todos os pacientes mostraram 
reparação óssea completa.  
 
2. Lesão Central de Células Gigantes 
 
          2.1) Considerações gerais 
 
Anteriormente, qualquer lesão óssea que apresentasse células gigantes era 
diagnosticada como tumor de células gigantes (TCG). A indistinção aumentava 
pelo reconhecimento de lesões ósseas com numerosas células gigantes 
multinucleadas histologicamente semelhantes, senão idênticas, em pacientes 
portadores de hiperparatireoidismo36. A reavaliação das lesões denominadas 
como TCG separou muitas delas em novas categorias. Um exemplo foi uma lesão 
interpretada por Jaffe37 (1953) como uma resposta a agressão, e designada  de  
granuloma  de  células  gigantes  reparador.  O termo reparador foi abolido, após o  
reconhecimento  de  que  muitas  dessas  lesões  não  apresentam esta  natureza  
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reparadora;  de  fato,  alguns  patologistas  substituem  inclusive  o termo 
“granuloma” por “lesão”, sendo assim, a melhor designação é dada por Lesão 
central de células gigantes(LCCG).   
A LCCG é uma das lesões benignas de origem conjuntiva que provoca 
significativas controvérsias na literatura. A despeito dos esforços concentrados 
para esclarecer a etiopatogenia, ainda permanecem dúvidas sobre estas lesões. 
De semelhante modo, ainda permanece uma discussão sobre a forma de 
tratamento mais adequada, e sua possível relação com o TCG. A LCCG é 
composta por fibroblastos fusiformes num estroma contendo quantidades variáveis 
de colágeno. Inúmeros canais vasculares pequenos estão evidentes lado a lado 
da lesão. Macrófagos carregados de hemossiderina são notados com freqüência, 
bem como eritrócitos extravasados.  Células gigantes multinucleadas estão 
presentes ao longo do estroma de tecido conjuntivo.  As células gigantes podem 
estar espalhadas uniformemente; todavia ficam freqüentemente agregadas ao 
redor dos vasos. As células de inflamação não são proeminentes, e, quando 
vistas, provavelmente são de natureza secundária. Focos de osteóide podem 
estar presentes, dispersos pelo estroma38.  
 
2.2) Tratamento 
O tratamento cirúrgico para a LCCG pode incluir a exérese por curetagem39-
41 ou ressecção em bloco42-44. Em alguns casos, a curetagem pode ser 
complementada com crioterapia44 ou ostectomia periférica43.   
Esta lesão também é tratada por muitos autores por meio de abordagens 
não cirúrgicas, como a administração de doses sistêmicas de calcitonina, a 
aplicação intra-lesional de corticosteróides e métodos menos comuns como a 
administração de  α-interferon46.  
Os índices de recidiva variam substancialmente na literatura, com números  
que  vão  de 0%  a 49%39,40,47,48,49. As lesões consideradas agressivas apresentam 
uma maior tendência a recidiva40,48,49.  Esta tendência a recidiva também está 
associada a pacientes mais jovens39,49. Bataineh  et  al.  (2002)51  avaliaram  o  
resultado  do  tratamento  cirúrgico  da LCCG em mandíbula, analisando 
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retrospectivamente todos os casos tratados em um  período  de  9  anos.  Dezoito  
pacientes  foram  tratados  por  meio  de  um procedimento  cirúrgico  
padronizado,  que  consistia  em  ressecção  da  lesão  associada a ostectomia 
periférica, preservando a continuidade do bordo inferior da mandíbula. Os tecidos 
moles em contato com a lesão também foram removidos.  Todos os pacientes 
foram acompanhados por um período de 1-9 anos (média de 3,9 anos), com um 
caso de recidiva e 11% de parestesias permanentes de lábio inferior. Os autores 
concluíram que esta modalidade de tratamento é satisfatória, com um 
restabelecimento funcional pós-operatório favorável e baixo índice de recidiva.   
O tratamento com administração intra-lesional de corticosteróide é 
preconizado por diversos autores51-57. Os protocolos incluem 6 injeções com 
intervalos semanais, por seis semanas, de não mais que 1 ml de triancinolona por 
1 cm radiográfico da lesão – associados a partes iguais de anestésico local51,52,53.  
          Uma  outra  modalidade  de  tratamento  clínico  da  LCCG,  introduzida  na  
literatura  por  Harris  (1993)59,  é  representada  pela  administração  de  
calcitonina58-63. A calcitonina é um hormônio com um efeito  direto  de  inibição  de  
osteoclastos,  causando  um  aumento  do  influxo  de cálcio para os ossos. É 
produzida pela influência de baixas concentrações séricas de cálcio, pelas células 
C na tireóide e em menor quantidade nas paratireóides e timo. Há dois tipos 
principais de calcitonina disponíveis para o uso terapêutico: a calcitonina de 
salmão e a humana. Como a calcitonina tem um efeito de inibição direto sobre 
osteoclastos, é empregado no tratamento de doenças com aumento na atividade 
osteoclástica, como a doença  de  Paget e em algumas  metástases ósseas.  Uma 
unidade de calcitonina é definida como a quantidade necessária para induzir 
hipocalcemia em ratos sob condições experimentais. Em humanos, no entanto, o 
efeito da calcitonina de salmão é mais forte que a de origem humana; em 
voluntários saudáveis, 50UI de calcitonina de salmão parece ser equipotente a 75-
90UI  de  calcitonina  humana63.  Contudo, a  calcitonina  humana parece  ter  
menos  propriedades  antigênicas.  Após  administração  subcutânea,  a maior  
concentração  plasmática  é  obtida  em  1  hora;  A  meia-vida  é  de  70-90 
8 
 
minutos61. A dose empregada para o tratamento da LCCG é empírica, derivada do  
tratamento  da  doença  de  Paget  e  de  osteoporose  pós-menopausa64.  
 
3. Queratocisto Odontogênico 
3.1 Considerações gerais 
 
Os cistos de origem odontogênica são aqueles que apresentam um 
revestimento derivado do epitélio produzido durante o desenvolvimento do dente, 
podendo ser derivado dos restos de Malassez, do epitélio reduzido do esmalte e 
do restos  da  lâmina  dental  (restos  de  Serres) como o queratocisto 
odontogênico (QO).    
Os QO foram inicialmente chamados de “cistos primordiais” devido a sua 
aparição em áreas onde havia uma agenesia dental65. Acreditava-se que o germe 
dentário ao invés de formar um dente gerava uma lesão cística. Entretanto, áreas 
radiolúcidas uni ou multiloculares, cujos conteúdos, quando analisados 
microscopicamente, apresentavam características idênticas a estes cistos, 
ocorriam  em  regiões  dos  maxilares  onde  todos  os  dentes  estavam  
presentes, fazendo com que essa hipótese não se sustentasse65. 
 
3.2) Tratamento 
Atualmente existe uma grande controvérsia entre os cirurgiões a respeito do 
melhor tratamento para os QO e sobre o que constitui um tratamento conservador 
ou radical66,. A maioria considera enucleação, curetagem, descompressão e 
marsupialização como tratamentos conservadores enquanto a ressecção em bloco 
e a ostectomia periférica, seguida ou não por enxerto ósseo é uma intervenção 
radical e geralmente aplicada aos QO recorrentes67.   
  O argumento dos que defendem uma abordagem mais radical é a 
possibilidade de recorrência66. Por outro lado os que defendem a utilização de 
tratamentos conservadores relatam como principal vantagem a preservação de 
estrutura óssea, tecidos moles e dentes associados aos QO, além de que estes 
procedimentos geralmente são menos traumáticos para o paciente, reduzindo ou 
eliminando gastos com  medicação  e  hospitalização68,69.  
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Autores como Bataineh e Alqudah (1998)66, relatam o tratamento de 32 QO 
por meio de ressecção marginal, observando um índice de recorrência de 0% 
durante um período de proservação que varia de 2 a 8 anos. Ele relata que uma 
abordagem mais radical diminui os riscos de recidiva, uma vez que há remoção de 
todo o epitélio da lesão. Desta maneira, requer menor cooperação do paciente. 
Além disso apenas um procedimento cirúrgico é realizado. 
Entretanto, ao buscarmos na literatura encontramos vários estudos em que 
o tratamento padrão foi realizado por meio da descompressão e um longo período 
de acompanhamento foi feito e, mesmo assim, baixas taxas de recorrência foram 
apresentadas. Desta forma, estes autores concluem que o tratamento conservador 
por meio da descompressão se mostrou eficaz70,71, 72. 
A descompressão é uma técnica em que se utiliza um dispositivo cilíndrico 
(como a borracha de um conta-gotas ou um dreno cirúrgico no interior da cavidade 
cística), com a finalidade de manter  uma  comunicação  continua  entre  o  meio  
bucal  e  o  interior  do  cisto. Usualmente ao utilizar esta técnica vai ocorrer uma 
união do epitélio da parede do cisto  e  a  mucosa,  tendo  como  resultado  final  a  
exteriorização  da  lesão  com  a vantagem  de  ter  a  certeza  de  que  a  
cavidade  sempre  estará  permeável. Adicionalmente o dispositivo colocado 
facilita  a  irrigação  da  cavidade  para  o paciente, sendo de grande ajuda para 
evitar o acúmulo de restos de alimentos e microorganismos que possam propiciar 
uma infecção secundaria69,70,71, 72.   
 
4. Materiais e Métodos 
 
          Esta pesquisa foi submetida à avaliação do Comitê de Ética em 
pesquisa, da FOP – Unicamp, tendo sido aprovada sob os protocolos N°: 
 174/2006, (anexo 1) 
 071/2006 (anexo 2)  
 057/2004 (anexo 3) 
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4.1 Material  
  
          Todos os prontuários pertencentes ao arquivo da Área de Cirurgia Buco-
Maxilo-Faciais  da  FOP-Unicamp foram avaliados,  no  período  compreendido  
de  janeiro  de  1995  a  julho  de  2011. Foram   selecionados   apenas   os   
prontuários   de   pacientes   com as seguintes lesões ósseas: 
 cisto   ósseo simples 
 lesão central de células gigantes 
 queratocisto odontogênico 
O diagnóstico definitivo foi confirmado  pelo  laudo  anatomopatológico, 
emitidos pela Área de Patologia da mesma Instituição.Todos os prontuários 
foram preenchidos  por  alunos  da  Pós-Graduação  em  Clínica  Odontológica  
–  Área  de concentração  em  Cirurgia  e  Traumatologia  Buco-Maxilo-Faciais,  
sob  supervisão constante dos professores que compõem esta Área, que 
também participaram de todas as etapas do tratamento instituído. Foi 
apresentado aos pacientes um termo de consentimento livre e esclarecido, no 
qual o mesmo autorizava seu tratamento e  a  utilização  dos  dados  do  seu  
prontuário  para  fins  de  pesquisa  ensino  e divulgação  em  jornais  e  
revistas  científicas,  respeitando-se  o  Código  de  Ética.             
Todos os prontuários de pacientes atendidos com diagnóstico definitivo de 
uma dessas lesões e confirmado por análise histológica foram incluídos na 
amostra, estando os pacientes em qualquer fase do tratamento. A coleta de  
dados, foi armazenada em uma planilha do programa Microsoft Excel 2007® 
otimizando  a  coleta  de  informações  referentes  à  identificação  do  
paciente, anamnese,   exame   físico,   hipóteses   diagnósticas,   
características   clínicas   e  radiográficas da lesão, exames complementares, 
data da instituição do tratamento inicial,  tipo  de  biópsia  empregada,  tipo  de  
tratamento,  evolução,  presença  de recidivas, tempo de proservação.  
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4.2 Método  
  
          A análise dos prontuários e a coleta dos dados foram realizadas pelo 
mesmo examinador, considerando as seguintes variáveis: 
 gênero 
 idade 
 aspectos clínicos 
 aspectos radiográficos 
 tratamento e proservação 
 recidiva 
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Treatment analysis of simple bone cyst treated by oral 
and maxillofacial surgery area of the Piracicaba Dental 
School from 1999 to 2011   
 
 
 
 
ABSTRACT  
 
 The  purpose  of  this  study is to evaluate  retrospectively  the  cases  of  
simple bone cyst (SBC), treated by the Oral and Maxillofacial Surgery Area of the 
Piracicaba Dental School - University of Campinas, between January 1999 and 
July 2011. It has been evaluated 10.543  clinical  handbooks,   where  12  patients   
presented  SBC.  All the cases occurred in patients that were  in  the  second  
decade  of  life,  with  mean  age  of  15.2  years. Mandible was involved in 100% 
of the cases, with high incidence on the symphisis (55%), followed by mandibular 
body (36%) and  mandibular  ramus  (9%).  Six  patients  reported history of 
trauma that occurred  between  2  to  9  years prior  to  the  diagnosis  of  the 
lesion.  All the patients were submitted to an incisional biopsy associated to a 
surgical exploration of the cystic cavity, which has represented the definitive 
treatment. The average time of proservation was 35,7 months, the shortest and the 
longest period of accompaniment had been 7 and 85 months respectively, period 
in which was not observed any recurrence. The treatment through exploratory 
surgery, carried through the moment of the biopsy, it was effective in all the cases 
of this study. The results of this study had contributed for the characterization of 
the SBC and they  helped us to conclude that: a) the etiology of the SBC might be 
a trauma,  with unrelated to gender  or  race; b) the  SBC  is  a  rare  injury,  that  
has   high  incidence on  the inferior jaw of the patients on the second decade of 
life; c) the discovery of SBC occurs during the routine examinations; the injury is 
not the complaint of the patient; d) the treatment of the SBC, through the surgical 
exploration, has revealed itself effective and safe.   
Key words: Treatment, Bone, Surgery, Epidemiology. 
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Introduction 
 
The simple bone cyst (SBC) is an uncommon injury, with a high incidence of 
1% of non-odontogenic cysts of the jaws. This injury is most often seen during the 
second decade of life, and its presence after this period is unusual. It occurs 
almost exclusively in the jaw with a predilection for the mandibular body and 
symphysis1, local trauma has been the more accepted cause. It is an osseous 
disease that on radiographic examination seems to be an apical periodontitis of 
endodontic origin. Caution is required over the establishment of the diagnosis  to 
avoid the root canal treatment and, also during surgical exploration, to prevent 
pulpal neurovascular bundle rupture1. 
According to DeTomaso and Hann, 19852, the typical clinical findings 
usually attributed to the SBC include the presence of a radiolucent area, well-
defined as unilocular, usually with sharp edges, especially among the roots of the 
premolars and mandibular molars3,4, the presence of associated dental elements of 
vitality, absence of tooth mobility, normal aspect of the overlying soft tissue, usually 
with no symptoms and lesion. It is essentially an empty cavity.  
Radiographically, the lesion appears as a radiolucent area that may or may 
not be well circumscribed. Margins are sometimes cortical in nature. The 
appearance of blurred between the teeth is a pathognomonic feature of this injury5. 
Due to the fact it is an asymptomatic lesion and has silent evolution, it is often 
discovered during the routine radiographs. Thus, radiography plays an important 
role in the diagnosis of SBC. Zegarelli et al. 19666, conducted a study which 
definitively proved the diagnosis of SBC, through the inspection and surgery in 17 
cases. In all cases, the cyst appeared as an intra-bone cavity, completely 
surrounded by the bone. In 8 patients, the cavity was completely empty, there were 
seven aero-blood fluids and, in two of them, was found the presence of 
hemorrhagic fluid. There was no lining epithelial tissue, which was confirmed by 
sending small fragments for microscopic examination, revealing the absence of the 
connective tissue and epithelial tissue. Among  many theories, according to Harnet 
et al,. 200841, 3 predominate: 1) an abnormality of osseous growth - some authors 
suspect that SBC may represent an “out of control” remodeling osseous area; 2) a 
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degenerating tumoral process - this theory of a tumoral degeneration process is 
based on clinical observations mostly reported in osteodystrophic pathological 
conditions, such as fibrous dysplasia and central giant cell granuloma; 3) a 
particular factor triggering hemorrhagic trauma43. 
 Several treatment options have been proposed. However, the 
recommended treatment is surgical exploration because it confirms the clinical and 
radiographic diagnosis after inspection of the cavity, which in most cases is either 
empty or full of a sero-sanguineous fluid. During surgical exploration,  the cavity 
may be filled of  blood, which can be later replaced by bone tissue 7. The purpose 
of this study was to evaluate the epidemiological characteristics of cases of SBC, 
treated by the division of Oral and Maxillofacial Surgery of the Piracicaba Dental 
School – UNICAMP from 1999 to 2011.   
 
Material and Methods 
This research was submitted to the evaluation of the Research Ethics 
Committee of FOP - UNICAMP, and was approved under the protocol n. 174/2006. 
Of all patients seen during the period of January 1999 to July 2011, we selected 
only the records of the patients with SBC whose final diagnosis was confirmed by 
histopathological report, issued by the Division of Pathology of the same institution. 
The patients were presented to a term of informed consent, which  allows the same 
treatment and use of data in their medical records, for research teaching and 
disclosure  in newspapers and journals. All charts of patients treated with definitive 
diagnosis of simple bone cyst confirmed by histopathology were included in the 
sample, with patients at any stage of treatment. 
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Figure 1. The region of the circle does not correspond specifically to the side, but the sum of right 
and left sides 
 
Results 
Twelve patients had been seen (6 women and 6 men), as shown in the table 
below. The average age of patients was 15.2 years; the oldest and the youngest 
were respectively 18 and 12 years. All patients were diagnosed with simple bone 
cyst, confirmed by sending samples obtained by histopathology. According to the 
location, it seems that all injuries occurred in the mandible, with the following 
proportion: 55% symphysis, followed by the body with 36% and finally branch with 
9% (figure 1). The presence of the symptom pain was reported in only one case. 
No other symptoms were reported by patients. However, a swelling in the region of 
the cyst was observed in 3 cases, only noticed after the visualization of the lesion 
in radiographs. The only case of pain related to the SBC was presented by a 
patient who presented swelling associated with injury. The radiographic 
appearance of radiolucency and unilocular was constant in all cases. A sclerotic 
halo was observed in most cases. The average size of the lesions was 32.8 mm X 
19.4 mm. The history of previous trauma was reported in 06 cases, a period that 
9% 
55% 
36% 
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ranged from two to nine years. There was no relation between the size of the 
lesion and the time elapsed in the history of trauma. The treatment performed for 
all cases was a surgical exploration and curettage of bone cyst walls. The 
presence of paresthesia after the completion of surgical exploration was not 
confirmed in any case. The average was 35.7 months, with the lowest and highest 
preservation period of 7 and 85 months respectively. During the follow-up (figure 2 
and 3) period  previously established, the presence of recurrence was not 
observed (table 1 and 2). 
 
Table 1 - general characteristics 
case gender age  region location Size 
 (mm) 
pain radiographic 
aspect 
Proserv. 
(months) 
trauma 
1 M 15  symphysis Median 30 X 17 no Unilocular 
radiolucent 
5 4 years 
2 M 18  body right 20 X 17 no Unilocular 
radiolucent 
30 no 
3 F 12  symphysis Median 24 X 20 no Unilocular 
radiolucent 
19 9 years 
4 F 16  ramus right 29 X 17 no Unilocular 
radiolucent 
63 no 
5 F 15  symphysis Median 30 X 17 no Unilocular 
radiolucent 
21 no 
6 M 15  symphysis Median 23 X 21 no Unilocular 
radiolucent 
34 no 
7 F 16  symphysis Median 50 X 20 no Unilocular 
radiolucent 
10 7 years 
8 F 14  symphysis Median 50 X 20 no Unilocular 
radiolucent 
19 no 
9 M 14  body left 24 X 22 yes Unilocular 
radiolucent 
7 no 
10 F 15  body right 51 X 20 no Unilocular 
radiolucent 
24 3 years 
11 M 18  body right 30 X 23 no Unilocular 
radiolucent 
81 2 years 
12 M 15  body left 25 X 16 no Unilocular 
radiolucent 
5 4 years 
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Table 2 - treatment and recurrence 
 
 
 
 
 
Discussion 
Regarding the location, the mandible was affected in 100% of our cases and 
06 cases were located in the region of the symphysis like Ballester et al. 200943.  
Those data is in agreement with the literature reviewed. Hansen et al. 197411, in 
the evaluation of 66 cases, found out that for lesions in the jaw, there was a high 
incidence of injuries involving the symphysis region.  
Regarding the age, 100% of the cases were diagnosed in individuals who 
were in the second decade of life. Similar results were observed in the literature, 
showing that the second decade of life is the most prevalent period for these 
lesions1,7,12,13,14,15,45.  
It is believed that the SBC is related to a process that begins from a local 
trauma8. In this theory, it is assumed that the cyst develops as a result of an 
intraosseous hematoma, caused by a trauma, in an area of spongy bone, where 
the failure in the organization of the clot, results in liquefaction and subsequent 
formation of a cystic cavity. The flaw in the organization would cause necrosis of 
bone trabecular. The removal of the trabecular bone and the organization of the 
clot are delayed due to the lack of reactive tissue on the surface of the cyst. Then 
the osteoclasts become differentiated in the opposite surface and remove the 
necrotic bone tissue. In the same time, undergo blood clot liquefaction, preventing 
the organization of the local tissue, which causes the formation of the cyst9.  
The presence of sero-bloody content was observed in 04 cases, and there 
was no correlation between the presence of content with trauma histories. 
According to Blum, 19298, the presence of fluid content is attributed to the theory-
traumatic bleeding, where the hematoma formed after a trauma may subsequently 
undergo lysis and become an empty hole. The presence of painful symptoms is 
nº cases treatment Recurrence 
% 
        
 
All cases 
 
curettage 
 
0 
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unusual for SBC16,17,18, occurring only with one patient. It has been attributed to the 
presence of painful symptoms, the bone lesions that have spread19. During bone 
growth, the nerves that are in proximity to the cystic cavity, can be compressed 
and generate a table of pain symptoms20. The largest lesion found in our study was 
50 mm long horizontal (mediolateral) by 22 mm of vertical extension (from the 
bottom edge of the alveolar ridge of the jaw). The occurrence of large lesions is an 
unusual finding21 and these lesions may represent the evolutionary stage 
reached14. In our study, all cases of SBC has been presented unilaterally. The 
occurrence of bilateral mandibular SBC is rare22.  
 
  
Figure 2. Preoperative                        Figure 3. postoperative – 60 days 
 
According to McDaniel and Stimson 198923, the lack of teeth is vitality 
associated with SBC and it was seen in approximately 10-15% of the cases. The 
loss of teeth is vitality associated with the injury after treatment is uncommon24, but 
can occur due to the trauma during the treatment. Based on the proximity of the 
lesion with the root of the teeth, Ruiz-Hubard & Harrison (1987)37 believe that 
periapical inflammation secondary to pulpal necrosis interferes in  the process of 
diagnosis of SBC, endodontic treatment and promotes the encouragement to start 
the process repair in the bone cavity. To Zunta and Newton, 198736, the 
endodontic treatment of SBC should be considered before, during or after surgery. 
For them, the commitment associated with endodontic tooth SBC can prevent the 
occurrence of bony healing. The lack of vitality presented as the main reason for 
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performing this treatment is not justified. As verified by Patrikiou et al., 198122 and 
Oliveira et al., 200018, endodontic therapy, known as the only form of treatment, 
was ineffective, and the growth of the lesion progressed normally, requiring 
surgical treatment. In our study it wasn't observed the presence of devitalized teeth 
associated with injury, or in the pre-operative or post-operative, with no indication 
of endodontic therapy occurred in any of the cases presented. Although it has been 
confirmed in 50% of the sample to previous trauma, it was the only factor that 
might be associated with the emergence of SBC. The origin of SBC from initial 
injury seems to be the triggering  factor in this injury 7,8,25. The lack of confirmation 
in other cases of trauma does not rule out the possibility that there may have been 
a subtle or trauma that the patient does not remember that it occurred. In the 
literature also seems to be a consensus that intramedullary hemorrhage is 
essential for the formation of SBC and occurring from the initial trauma8,13,26. 
As for treatment it is observed in the literature that many forms are used to 
bring better results12,27,28,29. The injection of autologous blood within the bone cavity 
to stimulate osteogenesis as proposed by Precious and McFadden, 198430, is 
based on the hypothesis that the precursors of fibroblasts that are circulating in the 
blood undergo a transformation by a mechanism not yet clarified. However, we do 
not believe that this method has any advantage over surgical exploration. The 
bleeding that occurs during the surgery from the walls of the bone and surgical 
access, forms a clot that is organized and ossification within a period from 6 to 24 
months23, being enough to promote the filling of the cavity bone. Various forms of 
treatment were applied for the treatment of SBC. For many scholars, this lesion 
behave as self-limiting injuries and they are capable of a spontaneous and 
complete remission. This view is supported by the fact that the SBC is rarely seen 
in older patients, above the third decade of life32. A view, shared by Blum, 195517, 
and Szerlip, 196610, found series of cases that presented spontaneous resolution 
without surgical intervention. In fact, to Blum, 193212, a needle aspiration  is a 
possible treatment for SBC, it is believed  that the penetration of the needle during 
the aspiration in the bone cavity could produce a bleeding with subsequent clot 
formation, this would stimulate connective tissue and capillary activity for bone 
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regeneration. The apparent ability of SBC a spontaneous healing process leads to 
some questions about its exact nature, as demonstrated by Stark and Sapp, 
199033. However, surgical exploration followed by curettage of the bony walls  
shows to be the  most used for SBC7,31,34,5,35,23. To Kaugars and Cale, 19877, 
surgical exploration is sufficient to promote resolution of the lesion, which can be 
observed radiographically after a few months complete filling of the cystic cavity. 
Oliveira et al. 200018, reports the surgical exploration of the SBC as an aggressive 
procedure to be  applied on children. But, like Magliocca et al., 200739, we do not 
believe that surgical exploration consists in an aggressive procedure, as well as 
fundamental, for the diagnosis that presents little morbidity compared to other 
procedures in the oral cavity. It is also reported in the literature that surgical 
exploration's disadvantages include the possibility of devitalized teeth or injuries to 
adjacent nerves that may be passing across the cavity36,40. However, we believe it 
is desirable wherever we find a radiolucent lesion with cystic features, we establish 
the histopathologic diagnosis of this lesion through a biopsy, which will confirm the 
diagnosis and avoid  an extensive intervention, likely if the injury  would have 
expanded. Therefore, we recommend surgical exploration and histological 
examination to confirm the diagnosis, even in cases where there is a clinical and 
radiographic diagnosis of SBC. Some questions are raised about the real need for 
endodontic treatment of dental elements after surgical treatment.  
According to Rodrigues and Estrela, 200842, the treatment consists of 
surgical exploration, curettage of the osseous socket and its subsequent filling with 
blood. The clinical and radiographic control of the healing process is essential, 
which in the present clinical case was performed during 6 months. The recurrence 
of the SBC of the jaw is rarely reported in the literature32, unlike the injuries that 
occur in extra-cranial skeleton, which are common.  In our study there was no 
presence of recurrence within the follow-up period. The radiographic monitoring as 
a treatment option without surgical exploration is not recommended, as advocated 
by Stark and Sapp, 199033, because the final diagnosis of SBC is only done 
through the exploration of the lesion13, so the error in diagnosis may be notable 7. 
The association of SBC with cement-osseous dysplasia as shown by Melrose 
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et al., 197638 is a rare situation. And the differential diagnosis is based on the 
presence of multiple foci radiopac that are often found inside the lesions, in 
cement-osseous dysplasia. We believe that all SBC should be treated with surgical 
exploration, because through this method, besides being an effective treatment, 
allows the collection of material for histopathological examination to confirm the 
final diagnosis, which is a critical step because is through this examination along 
with clinical and radiographic setting forth the type of injury, choosing the best 
method of treatment of diseases. Although surgical exploration has been shown to 
be effective, proactive observation by X-ray examinations at set intervals of time is 
essential because it allows you to perform a follow-up resolution of the lesion or, 
when present, diagnose recurrences. Further studies on SBC, in order to seek 
information that might characterize a final and consensual manner, are  important 
because, along with the previous studies,  they will allow a better understanding of 
the behavior of these lesions to be able to define a protocol for appropriate 
conduct. 
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Retrospective evaluation of conservative treatment in 
central giant cell Lesion by the Piracicaba Dental 
School from 1996 to 2011 
 
 
  Abstract  
The central giant cell lesion is a benign jaw's lesion, accounting for less than 
7% of all benign jaw's lesions. Its origin is unknown, but it has been suggested that 
genetic factors may be implicated. The central giant cell lesion demonstrates a 
variable clinical behavior, ranging from slowly growing painless swelling to rapidly 
expanding aggressive tumors, characterized by pain, local bone's destruction, root 
displacement or resorption and a significantly high recurrence rate. Surgical 
treatment represented by curettage with peripheral ostectomy or not is the most 
widely used procedure. However, other treatment options, such as intralesional 
corticosteroids, daily calcitonin administration or α-interferon, are advocated. The 
recurrence rate may be high (ranging from 0% to 49%), and it seems to depend on 
the clinical behavior, the treatment employed, and anatomic site involved. The aim 
of this study was to report the results of long-term follow up of the management of 
central giant cell lesion. A retrospective analysis was conducted from January 1996 
to July 2011, analyzing all cases of the Oral and Maxillofacial Area at Piracicaba 
Dental School. The sample was represented by 20 patients (9 Females; 11 males), 
with a mean age of 18.5 (ranging from 5 – 59) years, and the maxilla was involved 
in half of the cases. Regarding the treatment modality, the choice was based on 
characteristic lesions: six were treated by surgery (3 hospital and 3 outpatients). 
The remaining injuries (14) were treated with intra-lesional triamcinolone weekly 
associated with calcitonin (5 cases) or enucleation (two cases). The mean time of 
treatment with corticosteroids was 3.84 (±3.87) months, but in two cases calcitonin 
daily administration was initiated. The mean time of treatment with calcitonin was 
18.8 (±7.94) months, but in one case calcitonin did not seem to be effective. No 
case of recurrence was observed after a mean follow-up of 38.22 (ranging from 3 – 
174) months.  
Key-Words: Giant cell lesion, Treatment, Surgery, Glucocorticoids, Calcitonin 
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Introduction 
The central giant cell lesion (CGCL) is a benign osteolytic lesion whose 
nature is controversial and may be reactive, inflammatory, or neoplasic1,2. It is 
defined by the World Health Organization (WHO) as an intraosseous lesion 
consisting of cellular fibrous tissue containing multiple focus of hemorrhage, 
aggregations of multinucleated giant cells and occasionally trabeculae of bone 
cortical3. The CGCL affects predominantly young female adults4,5, and is a highly 
uncommon lesion, representing less than 7% of non-neoplastic lesions of the jaws. 
As for location, it occurs more frequently in the mandible and in the anterior 
region4,6. However, the CGCL does not only occur in the jaw. It is also found in 
other parts of the body as in ethmoid sinus, temporal bone of the metacarpal, 
humerus, rib, pelvis, femur and tibia7, 8,9,10. 
The lesion has a quite variable clinical behavior. At one end, it manifests 
itself as small lesion that shows no signs of aggression. At the other extreme, it is 
presented as multilocular lesions with large and frequent recurrences after 
enucleation and / or curettage, and there are often rapid growth, root resorption, 
paresthesia and pain. These differences in clinical behavior often influence the 
decision on the most appropriate to the case treatment modality and act as 
parameters to anticipate the evolution and prognosis of the case11-16.  
Radiographics features of CGCL are variable, and can be confused with 
several other injuries. The majority presents itself as an expansive radiolucent 
area, unilocular or multilocular, often crossed by bony septs21. Teeth displacement 
and / or root resorption are also findings that may be found14 predominantly in large 
lesions, in approximately 13.5% of the cases22. The margins of the lesion are 
described as well as defined in 56% of cases, poorly defined at 30% and diffuse in 
the remaining 14% 18. In the mandible, the CGCG can expand or even perforate 
the cortical bone. In the maxilla, the descriptions reported ranging from unilocular 
radiolucency to multilocular, with borders that can be well or poorly defined4, 22, 23. 
Lesions with histological features similar to how the TCG, the brown tumor 
of hyper-parathyroidism, the cherubism and aneurysmal bone cyst, previously 
confused, are currently recognized and addressed more specifically. Given this 
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new perspective, the differential diagnosis of this injury often includes laboratory 
examinations of serum parathyroid hormone, alkaline phosphatase, and 
examinations of DNA analysis. Histologically, it is composed of spindle-shaped 
fibroblasts in a stroma containing variable amounts of collagen. Numerous small 
vascular channels are evident alongside the lesion. Hemosiderin-laden 
macrophages are noted frequently, as well as extravasated erythrocytes. 
Multinucleated giant cells are present throughout the stromal tissue. Giant cells can 
be spread evenly, but are often clustered around the vessels. The inflammation 
cells are not prominent, and, when seen, are probably secondary in nature. Foci of 
osteoid may be present dispersed throughout estroma17. 
Several treatment modalities, both surgical and nonsurgical, are proposed 
for the treatment of CGCG. The methods of surgical treatment vary from curettage, 
with or without peripheral ostectomy, cryotherapy, or even en bloc resection. 
Nonsurgical treatment is represented by the administration of drugs such as 
steroids, calcitonin, α-interferon and radiotherapy, the latter being more frequent in 
the medical literature18-27.  
The recurrence rates vary widely in the literature, with numbers ranging from 0% to 
49% 4,12,28,30,31,32. The lesions considered aggressive are more likely to recur11, 28.30. 
Greater tendency to relapse is also associated with younger patients4, 28.29. 
  
1.Surgical 
Different types of treatment can be chosen, depending on the evolution of 
the injury and the present location. The results of surgical treatment of maxillary 
CGCL was described by Rawashdeh et al. at 200633. The sample consisted of 12 
patients with ages followed by a period of 2-9 years (mean 5 years). All patients 
were treated by curettage until healthy bone was found. In patients who had 
cortical bone perforation, the procedure was modified by performing peripheral 
ostectomy of about 2-3 mm and to ensure the removal of the entire affected 
mucosa. We observed recurrence in two patients, one was recorded in two 
episodes, also treated by curettage. The authors concluded that surgical treatment 
30 
 
by curettage and peripheral ostectomy is a satisfactory method of treatment, with a 
low recurrence rate.  
Bataineh et al. 200216 evaluated the results of surgical treatment in the 
CGCL jaw in hindsight of all cases treated during a period of nine years. Eigtheen 
patients were treated using a standardized surgical procedure, which consisted of 
marginal resection of the lesion with peripheral ostectomy, preserving the 
continuity of the bottom edge of the jaw. The soft tissues in contact with the lesion 
were also removed. All patients were followed for a period of 1-9 years (mean 3.9 
years) with a single relapse and 11% of permanent paresthesia of lower lip. The 
authors concluded that this modality of treatment is satisfactory, with a functional 
rehabilitation of post-operative recovery and low recurrence rate. 
In a study involving 83 patients by de Lange and Akker, 200522, in all cases 
patients were treated by enucleation and / or curettage except 3 cases, getting a 
recurrence rate of 26.3%. These 3 cases were treated by administration of 
calcitonin, and were represented by young patients (4, 11 and 13 years of age) 
showing aggressive lesions, and none of the patients presented signs or symptoms 
of recurrence after a follow-up period of 7 years. 
Tosco et. al., 200926 report their experience with en bloc resection of 18 
wide CGCL which had not been previously treated medically. Immediate 
reconstruction was carried out for all cases and in one, a fibula free flap was used 
to reconstruct the mandible. No recurrence was observed. After complete healing 
of the graft, prosthetic rehabilitation via implants was performed. This allowed the 
best functional and aesthetic results. 
 
2.Corticosteroids 
Treatment with intra-lesional administration of corticosteroid is 
recommended by several authors34-40. The protocols include six injections over 6 
weeks, with one injection each week for no more than 1 ml of triamcinolone 
acetonide for 1 cm of radiographic injury - associated with equal parts of local 
anesthetic34-40. Nogueira et. al35. related 21 cases of central giant-cell granuloma of 
the jaw were treated with intralesional injection of corticosteroids. The treatment 
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protocol adopted was intralesional injection of 20 mg/ml triamcinolone 
hexacetonide diluted in an anaesthetic solution of 2% lidocaine/epinephrine 
1:200,000 in the proportion 1:1;  1.0ml of the solution was infiltratedfor every 1 cm3 
of radiolucid area of the lesion, totalling 6 biweekly applications. Ten patients had 
aggressive lesions and 11 nonaggressive. Two patients showed a negative 
response to the treatment and underwent surgical resection, 4 showed a moderate 
response and 15 a good response. 8 of the 19 who had a moderate-to-good 
response to the drug treatment underwent osteoplasty to reestablish facial 
aesthetics. 
In these cases, only mature or dysplastic bone was observed, with the presence or 
absence of rare giant multinucleated cells. Abdo et al., 200541 reported the 
treatment of a female patient, 14 years old, with a recurrence of CGCL in the 
anterior mandible, which had previously been treated by enucleation. The patient 
received a weekly administration, showing signs of healing after four applications. 
There were no signs of recurrence after 18 months. 
 
3.Calcitonin 
Another way of clinical treatment of CGCL, introduced in literature by Harris 
in 199342, is represented by the administration of calcitonin5,29,42. Calcitonin is a 
hormone with a direct osteoclasts effect of inhibition, causing an increased influx of 
calcium into the bones, thus it is used to treat diseases with increased osteoclast 
activity, such as Paget's disease and bone metastases in some examples/patients. 
There are two main types of calcitonin available for therapeutic use: salmon and 
human calcitonin. Calcitonin is a unit defined as the amount required to induce 
hypocalcemia in rats under experimental conditions. In humans, however, the 
effect of salmon calcitonin is stronger than that of human origin and in healthy 
volunteers; 50 IU of salmon calcitonin appears to be equipotent to 75-90UI 
human43 calcitonin. However, the human calcitonin appears to have less antigenic 
properties. After subcutaneous administration, the highest plasma concentration is 
achieved in one hour, half-life is 70-90 minutes43. The dose used for the treatment 
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of CGCL is empirical, derived from the treatment of Paget's disease and 
postmenopausal osteoporosis5. 
Harris,199342, was a pioneer in using this drug, administered calcitonin in 
four patients with GCCL, in a period of 12 to 34 months. Among the four cases, 
three showed complete resolution of the lesion and no recurrence after five years 
of monitoring; the other case was not accompanied for this time, but showed 
significant reduction in size after one year. The treatment of two patients with 
mandibular CGCL was described by Pogrel et al. 19995. The first patient had a 
lesion in the 4th episode of recurrence, with a history of pathologic fracture of the 
jaw in its evolution. The second had a lesion of rapid growth, previously treated 
unsuccessfully with intra-lesional administration of corticosteroids according to the 
protocol Jacoway and Terry, 199436. Both patients had normal levels of Ca, P, 
alkaline phosphatase and PTH. They were treated by subcutaneous administration 
of 100 IU of calcitonin for an average period of 20 months; in one case, the route of 
administration was changed to intra-nasal 10 months after taking their doubled 
dose. Regression of the lesion was found only in the presence of fibrous tissue 
biopsy. The patients showed no evidence of recurrence after an average follow up 
of 13.5 months. De Lange et al. 199929, reported the treatment of CGCL in four 
patients. The patients were aged 4-18 years and had jaw injuries, predominantly in 
the anterior, and in one patient the lesion represented a 5th episode of recurrence. 
The examinations of calcium, phosphate and PTH were normal. In one of the 
patients, it was  previously tried treatment with intra-lesional administration of 
methylprednisolone, with no significant therapeutic effect. All patients were treated 
with human calcitonin by subcutaneous injection of 50-100 IU daily, subcutaneous 
administration was replaced by nasal administration in one patient, and the dose 
was doubled. The patients showed regression on the table, showing no signs of 
recurrence at least 1 year of follow up (ranging from 10 months to 3 years). 
 Lietman & Levine (2005)44 reported the treatment of a female patient, 9 
years old, with a right mandibular angle CGCL, who had two in her clinical surgical 
removal, treated with intra-lesional administration of corticosteroids, and 
subsequently interferon α-2. However, the injury did not appear to respond 
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favorably to previously established treatments. It was then initiated subcutaneous 
administration of calcitonin 100 IU / day, with the resolution of the situation after 
one year, and no signs of recurrence 3 years after stopping treatment. 
 
4.Other treatments 
Some authors recommend subcutaneous administration of interferon-α for 
some months27. Anti-angiogenic activity of α-interferon was discovered in 
laboratory investigations in the late 80's. It is used successfully for the treatment of 
large hemangiomas or vascular tumors of different organs. The reason for the use 
of this drug is related to a possible vascular nature of the CGCL. It was hoped to 
have an involution of the lesion from the anti-angiogenic properties of interferon27. 
However, this fact is not always documented. Lietman & Levine (2005)44 employed 
this drug in a lesion with a diagnosis of GCT in the jaw, not getting an adequate 
clinical response which led to a revision in diagnosis. Serum levels of endothelial 
growth factor (VEGF), a marker for GCT, were not elevated, it was not detected by 
immunohistochemistry the expression of factor VIII, a protein produced by 
endothelial cells that suggests intense vascularity. It was then obtained a diagnosis 
of CGCL, which was adequately treated with subcutaneous administration of 
calcitonin. Some authors recommend the ionizing radiation for the treatment of 
CGCL18, especially for 45 cases of lesions with difficult resection, when the patient 
refuses to undergo surgery or recurrence; however, the possibility of radio-
resistance or sarcomatous transformation should be considered45. Arda et al. 
(2003)46 defends the anti-angiogenic protocol with interferon-α by the lack of 
predictability of the efficacy of radiotherapy CGCL, and the risk of sarcomatous 
transformation involving its employment. 
  
Material and Methods   
This research was submitted and is under the Ethics in Research of FOP-
UNICAMP, protocol No. 071/2006. We used the records from the files of the Area 
of Oral and Maxillofacial Surgery FOP-UNICAMP of all patients seen during the 
period from January 1996 to July 2011, when the definitive diagnosis of CGCL was 
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confirmed by histopathological report, conducted by the Division of Pathology of 
the same institution. All charts were filled by students from the Postgraduate Dental 
Clinic - Concentration Area in Surgery and Maxillofacial, under constant 
supervision of the teachers who are part of the area. They participated directly and 
indirectly in all stages of the provided treatment. All charts of patients treated with 
definitive diagnosis of giant cell granuloma confirmed by histopathology and tests 
for exclusion of hyperparathyroidism were included in the sample, with patients at 
any stage of treatment. Exclusion criteria were considered by inadequate to fill the 
chart, the lack of consent for data use or abandonment of treatment. 
Data were tabulated on a spreadsheet program - Microsoft Excel for Windows ® 
XP 1, where they were subjected to descriptive analysis. Patients were separated 
according to gender, age, type of lesion, type of treatment and recurrence. 
Twelve patients (9 females, 11 males), with a total of 20 CGCL, attended by 
the Department of Piracicaba Dental School at University of Campinas  between 
1995 and 2011. In this study, the age range was 5 to 59 years (average, 18.5 
years). All the CGCL were diagnosed by histologic examination by the Department 
of Oral Pathology. All lesions were discovered by radiographic images, and the 
preoperative diagnoses of CGCL were obtained with biopsied specimens, 
confirmed postoperatively by histopathologic report. Besides surgical treatment, 
some forms of medical treatment were taken by our department, among them are 
the intra-lesional administration of corticosteroids, administration by nasal spray of 
salmon calcitonin, and a combination of both types of treatment, when necessary. 
Surgical treatment was performed in both ambulatory and hospital environment, 
and the anesthetic method determined this decision. Larger lesions with difficult 
surgical access and / or close to vital structures were treated under general 
anesthesia in a hospital environment. On the other hand, less complex cases were 
treated under local anesthesia in an outpatient setting. 
After intra and extraoral antisepsis and sterile drapes were affixed with the 
patient adequately anesthetized, a needle aspiration was performed on the lesion, 
for estimating its nature. After this maneuver and adequate incision and exposure 
of the lesion, it was carefully released with the aid of curettes Luke, trying to 
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remove it entirely. Where peripheral ostectomy was planned, spherical drills 
coupled with large low speed engines were used - under constant irrigation with 
saline. The flaps were repositioned and sutured with silk or absorbable sutures 3-
0/4-0. The postoperative medication was represented by analgesics, mouthwash 
with chlorhexidine 0.12% and anti-inflammatory drugs. Patients were evaluated 
clinically and radiographically usually in seven (with the sutures removed in due 
course - if indicated), 14, 30, 90 and 180 days. In the last two returns, it was 
commonly requested panoramic radiograph control. After this period, patients were 
reassessed every year, with observed variations in the commitment of patients to 
attend to returns. Corticosteroid treatment represented the first choice in cases 
where medical treatment was instituted. After intra and extra-oral antisepsis and 
affixed sterile fields, equal amounts of hexacetonide triamcinolone (Triancil ®, 
Apsen Pharmaceuticals, São Paulo, Brazil) and 2% lidocaine with epinephrine 
1:100,000 (ALPHACAINE ®, DFL, Rio de Janeiro, Brazil) were associated and 
managed with the aid of a needle 13 or 25 X 4.5 mm X 7 mm. A dose of 
approximately 1 ml per cm, calculated in radiolucency of the panoramic radiograph, 
was administered within the lesion through multiple punctures, with intervals of 7 
days between each application, and developments in the case were accompanied 
by appropriate clinical and radiographic findings. The degree of cooperation from 
patients, in some cases, interfered with the regularity of visits. After radiographic 
confirmation of bone healing, the applications were discontinued. Patients treated 
with calcitonin were instructed to apply it daily and at the same time, in the form of 
nasal spray salmon calcitonin 200 IU (200 Miacalcic ®, Novartis Biociências SA, 
São Paulo, Brazil), for a minimum of 1 year. 
 
Results 
Among the 20 cases studied (table 1), 9 were females and 11 males, as 
shown in the table below. The age range was 5 to 59 years (mean 18.5 years). Six 
cases were treated surgically. Three under general anesthesia and reconstruction 
with iliac crest (two cases) and tibia (one case). The two cases that were 
reconstructed with iliac crest underwent complementary treatment with distraction 
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osteogenesis The others three cases were treated under local anesthesia by 
enucleation (one case) and curettage (2 cases). The 14 remaining cases were 
treated conservatively, by corticosteroid and local anesthetic. In 5 of 14 patients, 
intra-lesional administration of corticosteroids was performed concomitantly with 
the administration of calcitonin nasal spray form, because treatment with intra-
lesional application of corticosteroids did not lead to an adequate clinical response 
(chart 1). The average duration of conservative treatment with corticosteroids was 
3.84 (± 3.87) months. In one case, there was no clinical response desired, and 
after 13.2 months of conservative treatment, it was decided to establish the 
surgical treatment. The average length of treatment with calcitonin was 18.8 (± 
7.94) months.  
Among the total sample, no cases of CGCL recurrence were found, 
regardless of treatment modality applied. In cases where medical treatment was 
instituted, the restoration of a normal trabecular bone or the remaining of a small 
radiolucent and well-defined area after completion of treatment and biopsy were 
considered as the resolution of the case. Therefore, the recurrence rate found for 
the sample was 0%, and the cases that still remain in treatment were excluded 
from this analysis. None of the patients were discharged, and are clinically and 
radiographically analyzed every year. 
The average time of follow up was 38.22 months, ranging from 3 to 174 (± 
51.68) months (figure 1 and 2). The shortest time of follow up was observed in one 
patient showing a small CGCL, treated surgically by curettage associated with 
peripheral ostectomy. 
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Table 1 (general characteristics) 
 
 
Discussion 
The restorative nature of CGCL, although quoted by Jaffe, 19532, and 
defended by two other authors, does not seem plausible, compared to numerous 
reports in the literature describing the clinical behavior of this lesion and evolution. 
However its low incidence is a factor that hinders a greater understanding of this 
injury, since there are no well-designed prospective studies with representative 
samples and with well-defined groups separated according to the type of CGCL - 
aggressive or not. The distribution of CGCL according to age in the first 2 decades 
of life is consistent with literature showing a higher incidence of this lesion in young 
case 
 
Size 
(cm) 
 
radiographic 
aspect 
 
Tooth 
displacement 
 
Dental 
resorption 
location region 
 
1 2,4 unilocular no no right maxilla 
2 2,8 multilocular yes no right jaw 
3 3,6 unilocular no no right maxilla 
4 5 unilocular no no right maxilla 
5 1,7 unilocular yes no right maxilla 
6 3,5 unilocular no yes right maxilla 
7 0,8 unilocular no no left maxilla 
8 2,9 unilocular yes no right jaw 
9 3,2 unilocular no no left jaw 
10 6,5 unilocular yes no left jaw 
11 2,3 unilocular yes no left maxilla 
12 2,8 unilocular yes no left maxilla 
13 2,6 unilocular no no right jaw 
14 6,4 multilocular no yes left maxilla 
15 3,3 multilocular no no right jaw 
16 4,7 unilocular no no symphysis jaw 
17 8,3 multilocular no no right jaw 
18 8,0 multilocular no no right jaw 
19 2,1 unilocular no no left maxilla 
20 10,1 unilocular yes no left jaw 
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adults, although it can occur at any age3, 5.18. There were no cases of CGCL in 
individuals of yellow color. The highest incidence of this lesion, about 75% of 
cases, occurred in white individuals.  
The literature reports a higher prevalence of CGCL5,12,19 in females3. 
However, the total cases analyzed (20), the highest prevalence of GCCG occurred 
in male subjects (55%), which is not consistent with other studies in the literature, 
even in a small percentage differential. However, the sample size does not allow 
speculation about a partiality between genders. 
In contrast to the literature by some authors3, 25, the CGCL distributed more 
frequently in the maxilla (55%) than in the mandible (45%). However, it showed a 
distribution similar to that described in these bones in the literature, primarily, 
affecting the anterior part of jaw, and being distributed uniformly in the jaw19, 25. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 patients 
 
6 
 surgery 
14 
 conservative 
3 
 outpatient 
3 
 hospital 
 
2 
1º)ressection 
 2º)iliac 
3º)Distration 
4º)implants 
1 
1º)ressection 
 2º)tibia 
2 - enucleation 
1 – curettage + peripheral ostectomy 
14 
 triamcinolone 
5 
 calcitonin 
2 
 enucleation 
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Chart 1 
The most appropriate approach to the treatment of CGCL is the subject of 
extensive discussion in the literature. CGCL, especially when it manifests itself 
aggressively, is a lesion difficult to manage, as their behaviors are difficult to 
predict, they are locally destructive and having high recurrence rates. Because it is 
an uncommon lesion, there are few studies with a large sample of patients and 
longer periods of follow-up. Additionally, the exact cellular origin and biology of this 
tumor are unknown. Besides being a locally destructive lesion with a high rate of 
recurrence, the pain is also a plausible symptom in patients with CGCL. Then, the 
time between the initiation of treatment and clinical response is an important factor 
for judging the best treatment option. At this point, surgery is of great importance, 
since the results are obtained immediately.  
In our sample, six cases treated by surgical approach. In three cases we 
performed a more conservative approach to surgery by curettage and enucleation, 
in the case of small lesions (<5cm) and slow clinical progression. Rawashdeh et 
al,. 200633,  related a sample consisted of 12 patients with ages followed by a 
period of 2-9 years (mean 5 years). All patients were treated by curettage until 
healthy bone was found. In patients who had cortical bone perforation, the 
procedure was modified by performing peripheral ostectomy of about 2-3 mm and 
to ensure the removal of the entire affected mucosa. They observed recurrence in 
two patients, one was recorded in two episodes, also treated by curettage. The 
authors concluded that surgical treatment by curettage and peripheral ostectomy is 
a satisfactory method of treatment, with a low recurrence rate. The other 3 patients 
underwent surgical resection and reconstruction with autogenous iliac crest bone 
(2) and tibia (1). According Chuong et al., 198611, lesions larger than 5 cm, with 
rapid evolution, more expansion or rupture of corticcal bone resorption associated 
with dental displacement or deserve a more aggressive approach. 
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Figure 1. Preoperative 
 
 
Figure 2. Postoperative – 5 years leter 
The traditional treatment for CGCL is surgical excision by curettage, and 
little controversy remains regarding this type of treatment; in some cases, 
curettage may be supplemented with criotheraphy26 or periferic ostectomy3,12, most 
frequently performed and does not require specific instruments to its realization. 
The terms usually employed for the surgical treatment is enucleation or CGCL 
curettage4, 24. Although some authors describe the en bloc resection as a treatment 
modality for aggressive lesions11, 16, this treatment option does not seem to be 
ideal. The resulting defect and the consequences of possible recurrences 
discourage its use. The morbidity and the resulting problems are the most negative 
factors associated with surgical treatment. Among the possible consequences, 
tooth loss may be associated with the surgical treatment of large CGCL; in 
pediatric patients, tooth germs often must be sacrificed, causing deformities of 
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varying degrees, often difficult to correct. This can be visualized by analyzing the 
case of two patients treated surgically in our hospital, whose treatment resulted in 
tooth loss and bone defects that are difficult to correct. In these cases, employed 
procedures were advanced osteopromotion, such as alveolar distraction 
osteogenesis, and autogenous bone graft associated with implant-supported 
rehabilitation for a minimum consequence arising from the treatment administered. 
 The intralesional administration of corticosteroids is an effective treatment 
option and recommended by several authors34-39. The hypothesis that boosted the 
use of corticosteroids was the histological similarity of the CGCL with sarcoid, as 
corticosteroids are effective against these, and the CGCL also respond to this 
treatment34. However, there is a consensus that this similarity is only superficial, as 
evidenced in a study conducted by imunohistoquimic47. However, the giant cell 
lesions have a fraction of which express receptors for glucocorticoids, the CD-68, 
and alpha-1-antichymotrypsin, markers for both macrophags48. Steroids should act, 
thus, removing any inflammatory component - reducing the number of monocytes - 
or the angiogenic lesion5. Another possible explanation for the success lies in the 
possible inhibition of bone resorption and inhibition of proliferation and 
osteoclasts49. 
Radiotherapy should not be considered as a viable option for the treatment 
of the jaws of CGCL, which are found more frequently in medical literature. In no 
case in our sample this method was used to supplement the surgical procedure, or 
treated with this method. The possibility of non-surgical treatment with other 
treatments safer and better documented, and the risk of malignant transformation 
contraindicate its use. 
The recurrence rate of CGCL can be as high as 45% or 50%4, but it is 
usually deemed to be situated between 0 to 20%, and is not associated with 
serious consequences as observed in recurrences of more aggressive tumors. In 
the lesions considered aggressive, a high recurrence rate is reported11.30. Greater 
tendency to relapse is also associated with younger patients4,15. These findings 
suggest that treatment by curettage of aggressive characteristics of injuries in 
young patients may not represent an appropriate treatment, especially considering 
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the possible consequences resulting from this treatment. However, patients with 
small CGCL might benefit more from surgical treatment, considering the discomfort 
caused by the duration of treatment and side effects of calcitonin. There is also a 
higher incidence of recurrence in the maxilla than the mandible, justified by 
anatomical characteristics between these regions that modify the surgery 
procedure33. In a similar way, the treatment modality employed also appear to 
influence the healing process, so that surgical treatment in the literature shows a 
greater tendency to relapse when compared to medical treatment with 
corticosteroids or calcitonin. This might occur because of the difficulty of complete 
surgical removal of the lesion, favoring the growth of residual lesions. Other factors 
not yet known may be related to the relapse of CGCL. Observing cherubism 
disease in giant cell lesions that occur due to genetic abnormalities, recurrences 
are not observed after curettage50. However, CGCL, relapses may occur 
frequently. The findings of this study confirm these data. The sample is 
represented mostly by non-aggressive lesions, with an average size of 3.3 cm in 
patients with mean age of 18.5 years, and most of them was treated by nonsurgical 
means. The absence of recurrence was the result of a combination of these 
factors. Thus a more or less aggressive treatment can be instituted depending on 
the degree of patient cooperation, the extent and aggressiveness of the lesion and 
the patient's age. 
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Retrospective evaluation of the effectiveness of conservative 
treatment of odontogenic keratocyst by the Piracicaba Dental 
School between the years 1995 - 2011 
 
 
 
 
 
Abstract 
The aim of our study was to retrospectively evaluate all odontogenic 
keratocysts (OKC) cases treated in the Oral and Maxillofacial Surgery Area at 
Piracicaba Dental School at University of Campinas in Sao Paulo, Brazil, between 
1995 and 2011. This study evaluated characteristics of 53 patients, all diagnosed 
with OKC by clinical, radiographic and histopathology analysis. The total number of 
injuries was 59 OKCs. After confirming the lesion, the data were published in the 
literature. The OKC prevailed in white and young (average age of 30 years) males. 
Most of the lesions (79%) occurred in posterior mandible. The most common 
histological pattern of OKC was parakeratinized (82%), and 11 (20%) out of 53 
patients presented impacted teeth associated with the lesion. Initial biopsy was 
performed in all patients, and all cases were treated according to the Department 
of Oral Diagnosis, Oral and Maxillofacial Surgery Area Protocol, which consists 
initially of decompression, followed by curettage of the remaining lesion, when 
necessary. Recurrence occurred in 8 patients (15%), who underwent enucleation 
and curettage of the remaining bone cavity. All cases are still monitored at least 
once a year, by panoramic radiographic; and, according to these results, all 
patients treated with decompression have recurrence rates similar or lower to 
those reported in the literature. Thus, we believe that conservative treatment, when 
possible, is effective with low morbidity. However, the strict monitoring is essential, 
since late manifestations of the lesion can occur. 
Key-words:  Keratocyst, Decompression, Recurrence, Follow-up. 
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Introduction 
The odontogenic keratocyst (OKC), or keratocyst odontogenic tumor 
(KCOT), is a lesion of odontogenic origin, which is classified as a developmental 
derived from the dental lamina. This lesion was first described in 1956 by 
Phillipsen1 and it is well known for its high recurrence rate2.  
It is an aggressive lesion, with greater growth potential than most of the 
lesions of odontogenic origin, whether cystic or not, and can reach a large size and 
produce bone destruction. This type of lesion presents a behavior similar to a 
benign tumor with high recurrence rates, which also differs significantly from other 
odontogenic lesions3, 4, 5. For this and other reasons, extensive research regarding 
this lesion has been carried out over the last 48 years6,7,8,9,10,11. Usually, it is 
asymptomatic in early stages, being discovered occasionally in radiographics12 
exams. The appearance of signs and symptoms are observed in advanced stages, 
when they reach larger dimensions, these being mainly the presence of dental 
malposition, expansion of cortical bone, spontaneous drainage of a yellowish 
material, pain (especially when infected), trismus and paresthesia13. This lesion 
can be associated, although not in all cases, with an impacted third molar. 
Radiographically, it appears as a unilocular or multilocular lesion with a scalloped 
contour. These characteristics are suggestive but not considered an unequivocal 
proof for the definitive diagnosis of OKC, because other lesions may exhibit similar 
features7. The rates of recurrence vary enormously, from a maximum of 62% to a 
minimum of 0%8. The majority of recurrent cases occur within the first 5 years after 
treatment8, 9, 10, 11, 14. 
Histologically, epithelial presents two variants: parakeratinized and 
orthokeratinized. Currently, these variants can be defined by some authors as the 
kind of nomenclature to be used in the literature. The term odontogenic keratocyst 
(OKC) is usually related to lesions that have a histological orthokeratinized 
characteristic type, whereas tumor odontogenic keratocyst (KCOT) is related to  
lesions with histological parakeratinized characteristic type. These variants can, 
then, define the treatment to be established, since injuries have orthokeratinized 
recurrence rate below 5%, and development is less invasive compared with 
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parakeratinized lesions that may present with a recurrence greater than 50%15,16,17. 
In our paper, more than 80% of lesions were histologic parakeratinized, however, 
more important than the histological variant, the level of aggressiveness and 
recurrence detected clinically were the determining factors in defining the kind of 
nomenclature. In our series, the lesions are often of slow evolution, being minimally 
invasive and with low rates of recurrence. In this way we describe them as 
odontogenic keratocysts18. 
Due exactly to structural differences (orthokeratinized and parakeratinized) 
and clinical behavior (recurrence and degree of aggressiveness), there is a major 
controversy among surgeons regarding the best treatment for OKC, and about 
what constitutes a conservative or radical7,8 treatment The majority considers 
enucleation, curettage, decompression and marsupialization a conservative 
treatment, while en block resection, sometimes followed by bone graft, is a radical 
intervention, and generally applied to applicants OKC. Most surgeons advocate 
complete removal with extension margins, or meticulous curettement of the 
surrounding tissues7. The enucleation alone is associated with the highest 
recurrence rates (range, 17% to 56%), usually when the lesion is removed in a 
fragmented fashion. To decrease the recurrence potential, various adjunctive 
therapies have been tried, including peripheral ostectomy, or the use of Carnoy’s 
solution, cryotherapy or electrocautery8-11,14. Decompression or marsupialization 
seem to be more conservative options in the treatment of OKC19,20. 
Marsupialization  was first described by Partsch in 188221,22 for the 
treatment of cystic lesions. This technique is based on the externalization of the 
cyst, through the creation of a surgical window in the oral mucosa and in the lesion 
wall. Their borders are then sutured to create an open cavity that communicates 
with the oral cavity. This procedure relieves pressure from the cystic fluid, allowing 
reduction of the cystic space and facilitating bone appositioning to the lesion 
walls19-24. Decompression and marsupialization are very similar techniques. The 
main difference between them lies in the creation of a surgical window in the oral 
mucosa and cystic membrane23, and in using a cylindrical device20 (like the rubber 
of a dropper) or a surgical rigid drain to prevent mucosal closure. This one has the 
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objective of maintaining a continuous communication between the oral cavity and 
the interior of the lesion. The decompression technique allows the permeability of 
the cavity because the union of the cyst epithelial wall with the mucous membrane 
results in the externalization of the lesion. In addition, the intraoral device facilitates 
the irrigation of the cavity. This helps to avoid food impaction and microorganism 
accumulation in the area, which could lead to an undesired secondary infection. In 
addition, after the surgical intervention, the cystic covering tends to become 
thicker, which facilitates its complete removal in a second surgery. The use of this 
technique is not new among the possible OKC treatments. 
Several reports describe the use of decompression to decrease the size of the 
cyst, after which it is definitively enucleated19-25. The use of these techniques alone 
are not reported commonly when a complete resolution of the OKC has been 
achieved24,25.Regarding the remaining epithelium after decompression of the 
lesion, August et al24 reported the differentiation of the OKC epithelium once 
treatment is carried out. Through histochemical analyses based on Cytokeratin-10 
tests, August et al24 accomplished the pre-operatory identification of the lesion in 
14 OKCs. After surgery, the same analysis was carried out again in the cystic 
epithelium to determine whether the marsupialization/decompression technique 
resulted in epithelial modulation, which is associated with lower recurrence rates. It 
was observed that 64% of the patients did not present Cytokeratin-10 in the 
epithelium analyzed, which shows the differentiation of this tissue, and therefore 
the lower rates of recurrence. Pogrel and Jordan26 reported the use of 
marsupialization as a definitive treatment of OKC. In this study, 10 patients were 
treated exclusively with marsupialization and decompression, achieving resolution 
of the lesions with a recurrence rate of 0%. 
The purpose of this study was to report our experience with the surgical treatment 
of 59 OKCs by the use of a defined protocol, based on decompression and 
posterior enucleation, or curettage if necessary, with reference to the recurrence 
rate. 
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Patients and methods 
Fifty three patients (23 females, 30 males), with a total of 59 OKCs, 
attended the OMS Department of the Piracicaba Dental School at University of 
Campinas between 1995 and 2011. In this study, the age range was 13 to 69 years 
(average of 30 years). All the OKCs were diagnosed by histologic examination by 
the Department of Oral Pathology. All lesions were discovered by radiographic 
images and the preoperative diagnoses of OKCs were obtained with biopsied 
specimens, confirmed postoperatively by histopathologic report. Our treatment 
protocol for cystic lesions consists of carrying out the initial biopsy and 
decompression of the lesion on the same day, if possible. Under local anesthesia 
(2% lidocaine with epinephrine 1:100,000), an aspirative biopsy was made with a 
10-ml syringe and #18 needle. A yellow, serous liquid or semi-solid content was 
obtained, matching the typical description of cystic lesion content. Posteriorly, a 
nº15 scalpel was used to carry out an elliptical incision in the attached gingival 
tissue of the alveolar ridge. Fragments of the cystic capsule, mucosa, and bone 
were taken and introduced into iodoform solution for histologic analyses. A sterile 
rubber foam dropper was preformed, fitted in the surgical windows, and fixed with 
non-absorbable suture (nylon 4.0). Rubber cylinders were used to allow permanent 
communication between the cyst and the oral cavity20. The postoperative care 
included the use of dipyrone via oral for pain control. In addition, daily irrigation of 
the cavity with saline solution and 0.12% chlorhexidine was carried out to prevent a 
secondary infection of the cavity. The irrigation procedure was made with a 20-ml 
syringe with no needle active point to prevent tissue injury. Irrigations were carried 
out 3 times/day with 60 ml of the irrigation solution. This started the same day of 
the surgery. Rubber cylinders were removed after 3 weeks and daily irrigation was 
maintained for another 6 to 9 months. Careful monitoring was based on monthly 
panoramic radiographies and clinic visits to determine lesion size regression as an 
effect of decompression and bone formation. If necessary, secondary curettage of 
the surrounding tissues was carried out after the decompression phase, once 
radiographic evaluation confirmed a size decrease of the lesion. Under local 
anesthetic, a horizontal incision was made in the alveolar ridge with a nº15 scalpel.  
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A mucoperiosteal flap was obtained with exposure of the lesion cavity. The 
secondary curettage of the cavity was carried out with a Lucas’ bone curette and 
the cavity was irrigated with saline solution. Finally, the flap was closed with 4.0 silk 
suture (Johnson & Johnson, Ethicon, Brazil). The use of topical 0.12% 
chlorhexidine solution twice a day was indicated for 2 weeks. In those cases, 
where treatment of the lesion consisted of enucleation only, a procedure similar to 
the one described above was used. Patients receive follow-up with clinical and 
serial panoramic radiographs at 7, 15, and 30 days. Ninety days after the 
procedure is done, patients are monitored periodically every 6 months. From the 
second year on, the patient is monitored once a year (annex 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chart 1 
Biopsy  
Pathological examination 
Confirmation of odontogenic keraticysts Keeping device for 21 days 
Irrigation 3x/day 
Device placement 
Request/evaluation panoramic radiographic 
1º consultation 
Great size and benign characteristic 
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Results 
Among these 53 patients diagnose with OKC, young and males prevailed, 
as shown in the table below. Most of the lesions (34 lesions, 57%) occurred in the 
angle of the mandible and mandibular ramus associated, or not, with other sizes. 
The most common histologic pattern of OKC was parakeratinized (82%), and 29 
out of 53 patients presented impacted teeth associated with the lesion. Forty seven 
OKCs (81%) were treated by only decompression or associated with curettage of 
the remaining lesion. Twelve OKCs (19%) were treated by enucleation and 
curettage only. Recurrence occurred in 8 of 53 patients (15%) with 11 OKCs out of 
59 lesions. These patients were treated initially with decompression (6 cases), or 
with enucleation and periferic ostectomy (2 cases). All recurrence cases were 
submitted to enucleation/curettage and peripheral osteotomies of the remaining 
bone cavity. All cases are still monitored at least once a year, by means of 
panoramic radiographics (figure 1 and 2). 
 
Table 1. General characterisctcs 
case 
 
Radiographic 
aspect 
 
 
Tooth 
envolved 
 
side location (nº) 
 
Initial treatment 
 
recurrence Recurrence 
treatment 
1 unilocular yes right ramus mand.(1) Enucleation + 
curettage 
yes enuc. + curet. + 
P.O 
2 unilocular yes right ramus mand.(1) descompression no -- 
3 multilocular yes right ramus mand.(1) descompression no -- 
4 multilocular no right ramus mand.(1) descompression no -- 
5 unilocular yes right body mand.(1) descompression no -- 
6 unilocular yes right maxilla(1) Enucleation + 
curettage 
no -- 
7 unilocular no -- symphysis(1) descompression no -- 
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8 multilocular yes widespread jaw(3) descompression yes enuc. + curet. + 
P.O 
9 unilocular yes right ramus mand.(1) descompression yes enuc. + curet. + 
P.O 
10 unilocular no left angle man.(1) descompression no -- 
11 unilocular no left ramus mand.(1) descompression yes enuc. + curet. + 
P.O 
12 unilocular no right body mand.(1) descompression no -- 
13 unilocular yes right ramus mand.(1) descompression no -- 
14 unilocular yes left body mand.(1) descompression no -- 
15 unilocular yes left body mand.(1) Enucleation + 
curettage 
no -- 
16 unilocular no right angle mand.(1) Enucleation + 
curettage 
no -- 
17 unilocular no -- symphysis(1) descompression no -- 
18 unilocular no right angle mand.(1) Enucleation + 
curettage 
no -- 
19 unilocular no left angle mand.(1) Enucleation + 
curettage 
no -- 
20 unilocular no left body mand.(1) descompression no -- 
21 multilocular yes left ramus mand.(1) descompression no -- 
22 multilocular yes widespread jaw(3) descompression no -- 
23 unilocular yes left Body/symph(1) descompression no -- 
24 multilocular yes right ramus/ang/ 
body (1) 
descompression no -- 
25 unilocular yes right body mand.(1) descompression no -- 
26 unilocular no right body mand.(1) descompression no -- 
27 unilocular no left ramus mand.(1) descompression no -- 
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28 unilocular yes left ramus/ang.(1) Enucleation + 
curettage 
no -- 
29 unilocular no right ramus mand.(1) descompression no -- 
30 multilocular yes left ramus/ang/ 
body (1) 
descompression no -- 
31 unilocular yes left angle/ body (1) descompression no -- 
32 unilocular no left ramus mand.(1) descompression yes enuc. + curet. + 
P.O 
33 unilocular no left ramus mand.(1) descompression no -- 
34 unilocular yes left ramus/body(2) descompression no -- 
35 unilocular yes right ramus mand.(1) descompression no -- 
36 unilocular no left angle mand.(1) Enucleation + 
curettage 
no -- 
37 unilocular yes left ramus mand.(1) descompression no -- 
38 unilocular no left maxilla(1) Enucleation + 
curettage 
no -- 
39 unilocular yes right ramus/ang.(1) descompression no -- 
40 unilocular yes left ramus/ang.(1) descompression no -- 
41 unilocular no left body mand.(1) descompression no -- 
42 multilocular yes right ramus/ang/ 
body (1) 
descompression no -- 
43 unilocular yes right angle mand.(1) Enucleation + 
curettage 
yes enuc. + curet. + 
P.O 
44 unilocular yes right ramus mand.(1) Enucleation + 
curettage 
no -- 
45 unilocular no right body mand.(1) Enucleation + 
curettage 
no -- 
46 unilocular no right ramus mand.(1) descompression no -- 
47 unilocular no right ramus mand.(1) descompression no -- 
48 unilocular no -- symphisis(1) descompression no -- 
49 unilocular no -- symphisis(1) descompression no -- 
50 unilocular no right body mand.(1) descompression yes enuc. + curet. + 
P.O 
51 unilocular yes right ramus/body(2) descompression yes enuc. + curet. + 
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* P.O = peripheral ostectomy /  ENUC. = enucleation /CURET. = curettage 
 
Discussion 
The treatment of OKC is still controversial, and this is due to their 
aggressive behavior and ability to recurrence as well as the lack of definition on 
what constitutes a conservative or radical14 treatment. 
On one side are those who advocate a treatment based on enucleation, 
curettage, decompression and marsupialization, regarded as conservative 
treatments. Many authors have shown the successful treatment of large OKCs 
using the technique of decompression and irrigation19,20,24,25. This treatment does 
require a cooperative patient who will irrigate the cyst on a regular basis and will 
follow up regularly. For this reason, only a select group of patients may be suitable 
for this treatment. The benefit of this treatment over more conventional approaches 
(enucleation, en bloc resection) lies in the minimal surgical morbidity. In addition, 
associated structures such as the inferior alveolar nerve and developing teeth are 
less vulnerable to damage19,21,26. Second, the argument of those who advocate a 
radical approach is the possibility of recurrence8, however, according to the 
findings of our study, the OKCs applicants are histologically similar to the original 
injury and they also can apply, again, conservative treatments. Thus, the majority 
of our patients (80%) were treated by decompression, avoiding the surgical access 
in areas of the lesion that contained teeth, important anatomical structures such as 
the inferior alveolar nerve, and also preventing the weakening of the mandibular 
bone structure, which could lead to fractures in the trans-or post-operative. 
The decompression and marsupialization techniques were based in the 
exteriorization of the cystic cavity and resulted in communication with the oral 
cavity20,23. These procedures relieve pressure of the cystic fluid, allowing shrinkage 
of the cystic space and the appositioning of bone to the cystic walls. Several 
reports describe the use of the decompression technique to decrease the size of 
P.O 
52 unilocular yes left body mand.(1) descompression no -- 
53 unilocular no right body mand.(1) descompression no -- 
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the cyst, after which it was definitively enucleated. The use of marsupialization for 
the treatment of cystic lesions is not new and was originally described by Partsch 
in the late 1800s21,22. However, it is not common and there is relatively little in the 
literature on the use of this technique alone for carrying out the complete resolution 
of OKC 20,24,26. In our sample, recurring lesions were small in dimension. The 
secondary treatment, based in curettage associated to the peripheral ostectomy, 
has been accomplished in all of the cases, reducing the chance of new 
recurrences. The main advantage of the conservative treatment is the preservation 
of bone structure, soft tissue and teeth associated to OKC, fact that is of great 
importance if we consider that most of the patients are young. These procedures 
are less traumatic for the patient, eliminating medication and hospitalization 
expenses, and in most cases, avoid the need to accomplish reconstruction through 
grafts or extensive reconstructions. In most of the cases in which the recession is 
the elected treatment, the need of accomplishing the reconstruction of the jaw 
through grafts of autogenous bone is imperative. Usually these reconstructions are 
accomplished in a second surgery, which translates into larger discomfort for the 
patient, and increase of the morbidity, increments in the costs of the treatment and 
time of recovery, among others. Additionally, in these cases, there may be a need 
to put on some type of reconstruction plate. This adds possible complications with 
the use of rigid fixation material such as the exhibition of the plate, dehiscence and 
infection, among other complications. 
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Figure 1. Preoperative                     Figure 2. postoperative – 1 year leter 
 
 
Time of duration of the decompression treatment (1 to 14 months) is one of 
the disadvantages of this technique. In fact, this is one of the main causes of 
abandonment of the treatment by the patient because of loss of interest in proper 
irrigation treatment and attendance of periodic controls. In spite of being a 
technique that requires prolonged postoperative treatment and special 
considerations (like the ones mentioned above), and even a second surgical 
procedure in order to curette the remaining cystic cavity, it is a technique that 
allows the professional to offer the correct treatment and save hospital expenses 
that would increase with other complicated procedures that require general 
anesthesia and hospitalization. The technique is then an ideal alternative 
procedure for the treatment of odontogenic keratocysts that, in addition to being 
conservative (if compared with the enucleation technique), is well-adapted to the 
latin american reality, making the “cost-benefit” of the technique one of its more 
important advantages.  
 
The recurrence rate observed among our sample was 14.3%. In comparison 
with other important published  studies7,14,20,25,27-42, we obtained results within the 
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average with a more conservative approach.  
Autor ( es )  year  Nº cases  Recurrence % 
PINDBORG ; HANSEN         1963     16 62 
TOLLER   1967         55   51 
RUD ; PINDBORG   1969         21   33 
PANDERS ; HADDERS      1969         22   14 
BROWNE   1970         85   25 
McIVOR   1972         43   05 
PAYNE   1972         20   45 
RITTERSMA ; VAN GOOL      1972         48   32 
DONOFF et al..       1972         13   15 
FORSSELL et al 1974         38   29 
EVERSOLE et al..   1975         35   20 
BRANNON       1976         283   12 
HODGKINSON et al..       1978         74   39 
VEDTOFTE ; PRAETORIUS       1979         57   51 
FORSSELL       1980         121   40 
VOORSMITH et al., 1981 52  13 
AHLFORS et al..    1984         255   27 
ZACHARIADES et al..    1985         16   25 
PARTRIDGE ; TOWERS    1987         45   27 
FORSSELL et al..    1988         75   43 
BRONDUM ; JENSEN     1991       44  18 
MARKER et al..       1996         23   8,7 
DAMMER et al..    1997         52   06 
BATAINEH ; Al QUDAH       1998         31   00 
STOELINGA P    2001         82   11 
SCHMIDT e POGREL 2001 26 11.5 
AUGUST et al..   2003         11   18 
POGREL & JORDAN   2004         10   00 
MORGAN et al 2005 40 22.5 
CHIRAPATHOMSAKUL et al 2006 51 22.6 
MAURETTE et al 2006 30 14.3 
KOLOKYTHAS 2007 22 9 
ARNNOP et al 2009 120 26 
BOFFANO et al 2010 261 11.9 
ZECHA 2010 137 23.5 
MARANO; MORAES 2011 59 15 
Chart 2 
 
If we sum up the advantages of a conservative approach, like the one we 
suggest, versus a more radical treatment, the decompression treatment protocol 
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stands up as an equally effective, cheaper, and simpler procedure for the treatment 
of OKC if the patient can be closely monitored and periodically evaluated (clinically 
and radiographically). All cases are still monitored at least once a year, by means 
of panoramic radiographics, differently described by Stoelinga17 and August24. 
These authors explain the necessity to observe a long follow-up to consider a 
complete resolution of the OKC. In 2003, August et al.24, examined the nature of 
the cyst lining before and after decompression with cytokeratin stains and reported 
positive cytokeratin-10 staining in the predecompression biopsy, and negative 
cytokeratin-10 stains in the post decompression specimen. In 3, 6, 9, and 12-
month samples, a return to more normal oral epithelium within 9 months of 
decompression treatment was indicated. Several studies suggest that the largest 
number of recurrences of OKC occur during the first 5 years after the initial 
treatment period (about 70%)20-22. For this reason the annual radiographic control 
of these patients is recommended for an undetermined time8,43,44. According to the 
results, we can conclude that OKC treated with decompression presents similar 
recurrence rates to those reported in the literature. This demonstrates that this 
method of treatment for OKC offers a conservative and effective option with low 
morbidity and similar recurrence rates to those reported in the literature. However, 
the closes follow up and frequent control is of addition importance to the treatment 
success. 
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CONCLUSÃO 
 
 Os tratamentos adotados pela área de CTBMF da FOP-Unicamp 
para as lesões: cisto ósseo traumático, Granuloma central de células gigantes e  
Queratocisto odontogênico se mostraram efetivos e com resultados semelhantes 
aos de outros trabalhos na literatura, sendo que a escolha do tratamento a ser 
realizado deve levar sempre em consideração o tipo e tamanho da lesão, bem 
como as condições clínicas e radiográficas da lesão, assim como a colaboração 
do paciente. 
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